PAC will probe new HSE pharma deal costs
Probe comes amid concerns around the purported savings attached to the agreement
Public Accounts Committee chairman Sean Fleming intends to probe the recent drug pricing deal amid concerns around the purported savings attached to the agreement.
Independent journalism every day
With digital access you can read The Business Post whenever, wherever, and however you want.
- Unlimited access to all sections of The Business Post on desktop, tablet and mobile.
- Breaking news, comment and analysis from the best Business Post writers seven days a week.
- Live blogs of major news events
- Videos and podcasts from some of the industry's most respected journalists such as Tom Lyons, Susan Mitchell and Ian Guider
- Access to The Business Post's extensive archive
